Effect of Ginger (Zinger offiicinale Roscoe) on patients with slow coronary flow

Phase 2

Recruiting

Conditions: Coronary slow flow syndrome.
Other forms of angina pectoris
I20.8

Registration Number: IRCT20230625058582N1

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 48

Inclusion Criteria

Consent to admission to the study
Age more than 30 years old
Patients who have less than 50% stenosis in each of the 3 main coronary arteries in their coronary angiography and have delayed filling in at least one of the coronary arteries and have slow coronary flow in a corrected TIMI frame count of more than 27 frames per second

Exclusion Criteria

Stomach ulcers or duodenal ulcers
Taking anticoagulants such as warfarin, aspirin and enoxaparin
Breastfeeding or pregnancy
Consumption of omega 3 (fish oil), ciprofloxacin, loratadine, citalopram, montelukast, and levothyroxine
Kidney stone
History of known congenital heart disease
History of any cardiovascular diseases other than mild coronary atherosclerosis

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in the score of quality of life according to the EuroQol-VAS scale (0-100; 100 is the best quality of life and 0 is the worst quality of life). Timepoint: Before intervention and one month after beginning the intervention. Method of measurement: According to the EuroQol-VAS scale (0-100; 100 is the best quality of life and 0 is the worst quality of life).

Secondary Outcome Measures

Name	Time	Method
Frequent pain during the day. Timepoint: Before intervention and one months after beginning the intervention. Method of measurement: Checklist.;Duration of pain in minutes. Timepoint: Before intervention and one months after beginning the intervention. Method of measurement: Checklist.;Quality of life according to Seattle Angina Questionare. Timepoint: Before intervention and one months after beginning the intervention. Method of measurement: Seattle Angina Questionare.